As of 2025-07-01, the Relative Valuation of Mayne Pharma Group Ltd (MYX.AX) is (17.53) AUD. This relative valuation is based on P/E multiples. With the latest stock price at 5.00 AUD, the upside of Mayne Pharma Group Ltd based on Relative Valuation is -450.7%.
The range of the Relative Valuation is (16.92) - (18.10) AUD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 14.6x | 12.6x |
| Forward P/E multiples | 8.9x - 11.4x | 9.5x |
| Fair Price | (16.92) - (18.10) | (17.53) |
| Upside | -438.5% - -462.0% | -450.7% |
| Date | P/E |
| 2025-06-27 | -3.21 |
| 2025-06-26 | -3.20 |
| 2025-06-25 | -3.14 |
| 2025-06-24 | -3.19 |
| 2025-06-23 | -3.09 |
| 2025-06-20 | -3.22 |
| 2025-06-19 | -3.29 |
| 2025-06-18 | -3.34 |
| 2025-06-17 | -3.28 |
| 2025-06-16 | -3.18 |
| 2025-06-13 | -3.27 |
| 2025-06-12 | -3.19 |
| 2025-06-11 | -3.23 |
| 2025-06-10 | -3.32 |
| 2025-06-06 | -3.16 |
| 2025-06-05 | -3.09 |
| 2025-06-04 | -2.79 |
| 2025-06-03 | -2.99 |
| 2025-06-02 | -3.08 |
| 2025-05-30 | -3.12 |
| 2025-05-29 | -3.18 |
| 2025-05-28 | -3.10 |
| 2025-05-27 | -3.07 |
| 2025-05-26 | -3.07 |
| 2025-05-23 | -3.02 |
| 2025-05-22 | -2.74 |
| 2025-05-21 | -2.85 |
| 2025-05-16 | -4.09 |
| 2025-05-15 | -3.94 |
| 2025-05-14 | -3.72 |
| 2025-05-13 | -4.28 |
| 2025-05-12 | -4.33 |
| 2025-05-09 | -4.48 |
| 2025-05-08 | -4.48 |
| 2025-05-07 | -4.46 |
| 2025-05-06 | -4.35 |
| 2025-05-05 | -4.36 |
| 2025-05-02 | -4.41 |
| 2025-05-01 | -4.41 |
| 2025-04-30 | -4.41 |
| 2025-04-29 | -4.43 |
| 2025-04-28 | -4.40 |
| 2025-04-24 | -4.42 |
| 2025-04-23 | -4.36 |
| 2025-04-22 | -4.43 |
| 2025-04-17 | -4.44 |
| 2025-04-16 | -4.38 |
| 2025-04-15 | -4.41 |
| 2025-04-14 | -4.39 |
| 2025-04-11 | -4.39 |